Position in DHR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$301,148
+$4,424 QoQ
Shares Held
1,581
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,590
of 2,098 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026STUDIO INVESTMENT MANAGEMENT LLC holds $645,080 across 2 Diagnostics & Research names. DHR ranks #2 (46.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
686 | $343,932 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
1,581 | $301,148 |
All Filings in DHR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,148 | 1,581 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $296,724 | 1,565 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $350,247 | 1,530 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $302,346 | 1,525 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $319,422 | 1,617 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $329,230 | 1,606 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $337,438 | 1,470 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $402,850 | 1,449 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $347,291 | 1,390 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $332,377 | 1,331 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $276,913 | 1,197 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $340,641 | 1,373 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $41,280 | 172 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||